Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Anabolics in osteoporosis: the emerging therapeutic tool.
Trivedi R, Mithal A, Chattopadhyay N.
Curr Mol Med. 2010 Feb;10(1):14-28. Review.
Similar articles
Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT, Christensen PM, Ejersted C, Langdahl BL.
Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):260-70. Review.
Anabolic skeletal therapy for osteoporosis.
Girotra M, Rubin MR, Bilezikian JP.
Arq Bras Endocrinol Metabol. 2006 Aug;50(4):745-54. Review.
Investigational anabolic therapies for osteoporosis.
Trivedi R, Goswami R, Chattopadhyay N.
Expert Opin Investig Drugs. 2010 Aug;19(8):995-1005. doi: 10.1517/13543784.2010.501077. Review.
Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?
Treat Endocrinol. 2006;5(6):347-58.
Strontium ranelate in osteoporosis.
Reginster JY.
Curr Pharm Des. 2002;8(21):1907-16. Review.
[Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP.
Wien Klin Wochenschr. 2005 Nov;117(21-22):728-38. Review. German.
[Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D, Frey D, Frey-Rindova P, Goerres G, Michel BA.
Z Rheumatol. 2003 Dec;62(6):512-7. Review. German.
[Anabolic treatment for osteoporosis: PTH treatment].
Kaji H, Sugimoto T.
Clin Calcium. 2006 Sep;16(9):1480-85. Review. Japanese.
Drug combination strategies for osteoporosis.
Audran M.
Joint Bone Spine. 2006 Jul;73(4):374-8. Epub 2006 May 6. Review.
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
Neuprez A, Hiligsmann M, Scholtissen S, Bruyere O, Reginster JY.
Adv Ther. 2008 Dec;25(12):1235-56. doi: 10.1007/s12325-008-0125-8. Review.
Treatment of osteoporosis with parathyroid hormone and teriparatide.
Pleiner-Duxneuner J, Zwettler E, Paschalis E, Roschger P, Nell-Duxneuner V, Klaushofer K.
Calcif Tissue Int. 2009 Mar;84(3):159-70. doi: 10.1007/s00223-009-9218-x. Epub 2009 Feb 3. Review. Erratum in: Calcif Tissue Int. 2009 Nov;85(5):463.
The potential of parathyroid hormone as a therapy for osteoporosis.
Rubin MR, Bilezikian JP.
Int J Fertil Womens Med. 2002 May-Jun;47(3):103-15. Review.
Strontium as therapy for osteoporosis.
Marie PJ.
Curr Opin Pharmacol. 2005 Dec;5(6):633-6. Epub 2005 Sep 23. Review.
PTH (1-34): a novel anabolic drug for the treatment of osteoporosis.
Holick MF.
South Med J. 2005 Nov;98(11):1114-7. Review.
Emerging anabolic treatments in osteoporosis.
Mosekilde L, Tørring O, Rejnmark L.
Curr Drug Saf. 2011 Apr;6(2):62-74. Review.
Parathyroid hormone as an anabolic therapy for women and men.
Bilezikian JP, Rubin MR, Finkelstein JS.
J Endocrinol Invest. 2005;28(8 Suppl):41-9. Review.
The cellular and clinical parameters of anabolic therapy for osteoporosis.
Rosen CJ.
Crit Rev Eukaryot Gene Expr. 2003;13(1):25-38. Review.
Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Epstein S.
Clin Ther. 2006 Feb;28(2):151-73. Review.
Anabolic agents for treating postmenopausal osteoporosis.
Meunier PJ.
Joint Bone Spine. 2001 Dec;68(6):576-81. Review.
Filters: Manage Filters